Association of p53 and CDKN1A genotypes with endometriosis

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4301-4306

  Ying, Tsung Ho ^a   Tseng, Chih Jen ^a   Tsai, Su Ju ^b   Hsieh, Shu Ching ^a   Lee, Hong Zin ^c   Hsieh, Yi Hsien ^a   Bau, Da Tian ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CDKN1A WAF CIP1; Endometriosis; Genotype; p21; p53; Polymorphism

Indexed keywords

ARGININE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROLINE; PROTEIN P53;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TAIWAN;

ADULT; ALLELES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CODON; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENES, P53; GENOTYPE; HAPLOTYPES; HUMANS; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855183595     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Halis G and Arici A: Endometriosis and inflammation in infertility. Ann NY Acad Sci 1034: 300-315, 2004. (Pubitemid 40362369)
2. Varma R, Rollason T, Gupta JK and Maher ER: Endometriosis and the neoplastic process. Reproduction 127: 293-304, 2004. (Pubitemid 38425689)
3. Sampson JA: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 14: 422-469, 1927.
4. Costa IR, Silva RC, Frare AB, Silva CT, Bordin BM, Souza SR, Ribeiro Junior CL and Moura KK: Polymorphism of the progesterone receptor gene associated with endometriosis in patients from Goias, Brazil. Genet Mol Res 10: 1364-1370, 2011.
5. Altinkaya SO, Ugur M, Ceylaner G, Ozat M, Gungor T and Ceylaner S: Vascular endothelial growth factor +405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women. Arch Gynecol Obstet 283: 267-272, 2011.
6. Hsieh YY, Bau DT, Chang CC, Tsai CH, Chen CP and Tsai FJ: XRCC4 codon 247*A and XRCC4 promoter -1394*T-related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis. Mol Reprod Dev 75: 946-951, 2008. (Pubitemid 351438960)
7. Bau DT, Hsieh YY, Wan L, Wang RF, Liao CC, Ue CC, Lin CC, Tsai CH and Tsai FJ: Polymorphism of XRCC1 codon Arg 399 Gln is associated with higher susceptibility to endometriosis. Chin J Physiol 50: 326-329, 2007.
8. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ and Campbell IG: Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 56: 3534-3539, 1996. (Pubitemid 26251649)
9. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994. (Pubitemid 24289415)
10. Ralhan R, Agarwal S, Mathur M, Wasylyk B and Srivastava A: Association between polymorphism in p21 (WAF1/CIP1) cyclin-dependent kinase inhibitor gene and human oral cancer. Clin Cancer Res 6: 2440-2447, 2000. (Pubitemid 30399213)
11. Sato M, Kawamata H, Harada K, Nakashiro K, Ikeda Y, Gohda H, Yoshida H, Nishida T, Ono K, Kinoshita M and Adachi M: Induction of cyclin-dependent kinase inhibitor, p21/WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl) -1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene. Cancer Lett 112: 181-189, 1997. (Pubitemid 27104293)
12. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234, 1998. (Pubitemid 28261713)
13. Heiland A, Langerod A, Johnsen H, Olsen AO, Skovlund E and Borresen-Dale AL: p53 polymorphism and risk of cervical cancer. Nature 396: 530-531; author reply 532, 1998.
14. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF and Chen CJ: A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29: 697-702, 1999.
15. Wang NM, Tsai CH, Yeh KT, Chen SJ and Chang JG: P53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the Chinese. Int J Mol Med 4: 249-252, 1999.
16. Bischoff FZ, Heard M and Simpson JL: Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis. J Reprod Immunol 55: 49-64, 2002. (Pubitemid 34626151)
17. Mhawech P, Kinkel K, Vlastos G and Pelte MF: Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study. Int J Gynecol Pathol 21: 401-406, 2002.
18. Vercellini P, Trecca D, Oldani S, Fracchiolla NS, Neri A and Crosignani PG: Analysis of p53 and RAS gene mutations in endometriosis. Gynecol Obstet Invest 38: 70-71, 1994. (Pubitemid 24203874)
19. Schneider J, Jimenez E, Rodriguez F and del Tanago JG: c-MYC, C-ERB-B2, NM23 and p53 expression in human endometriosis. Oncol Rep 5: 49-52, 1998. (Pubitemid 28039816)
20. Horiuchi A, Osada R, Nakayama K, Toki T, Nikaido T and Fujii S: Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. Gynecol Oncol 70: 295-299, 1998. (Pubitemid 28430948)
21. Chen J, Jackson PK, Kirschner MW and Dutta A: Separate domains of p21 involved in the inhibition of CDK kinase and PCNA. Nature 374: 386-388, 1995.
22. Xiong Y, Zhang H and Beach D: Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7: 1572-1583, 1993. (Pubitemid 23234350)
23. 1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
24. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406, 1994. (Pubitemid 24338472)
25. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994. (Pubitemid 24225956)
26. Yin Y, Solomon G, Deng C and Barrett JC: Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol Carcinog 24: 15-24, 1999. (Pubitemid 29070239)
27. WAF1/CIP1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 18: 1131-1138, 1999.
28. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995.
29. Elbendary AA, Cirisano FD, Evans AC, Jr., Davis PL, Iglehart JD, Marks JR and Berchuck A: Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 2: 1571-1575, 1996. (Pubitemid 126447452)
30. Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, Bartek J and Bosch FX: Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 74: 383-389, 1997. (Pubitemid 27400156)
31. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV and Fontana JA: Mechanisms of regulation of WAF1/CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415, 1994. (Pubitemid 24359376)
32. WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557-1564, 1996.
33. Bahl R, Arora S, Nath N, Mathur M, Shukla NK and Ralhan R: Novel polymorphism in p21(WAF1/CIP1) cyclin-dependent kinase inhibitor gene: association with human esophageal cancer. Oncogene 19: 323-328, 2000. (Pubitemid 30077331)
34. Xi YG, Ding KY, Ren YH, Shen Y and Ke Y: Esophageal cancer in Chinese population: no polymorphism in codon 149 of P21 (WAF1/CIP1) cyclin-dependent kinase gene. Oncogene 21: 7745-7748, 2002. (Pubitemid 35398820)
35. Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD and Lin CC: p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. J Clin Lab Anal 15: 184-187, 2001. (Pubitemid 32642738)
36. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994. (Pubitemid 24299821)
37. Lai KC, Chen WC, Jeng LB, Li SY, Chou MC and Tsai FJ: Association of genetic polymorphisms of MK, IL-4, p16, p21, p53 genes and human gastric cancer in Taiwan. Eur J Surg Oncol 31: 1135-1140, 2005.
38. Jones JS, Chi X, Gu X, Lynch PM, Amos CI and Frazier ML: p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res 10: 5845-5849, 2004. (Pubitemid 39180964)
39. Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK and Huang CH: p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Cancer Epidemiol Biomarkers Prev 13: 2217-2224, 2004. (Pubitemid 40054320)
40. Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB and Lee HP: p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecol Oncol 93: 499-505, 2004. (Pubitemid 38507625)
41. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991. (Pubitemid 21917115)
42. Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, Lee CC and Tsai FJ: Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwanese patients. Anticancer Res 27: 1559-1564, 2007. (Pubitemid 46807237)
43. Soulitzis N, Sourvinos G, Dokianakis DN and Spandidos DA: p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179: 175-183, 2002. (Pubitemid 34215109)
44. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, Farthing MJ, Alderson D and Holly J: Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 9: 2151-2156, 2003. (Pubitemid 36687637)
45. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF and Spitz MR: p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94: 681-690, 2002. (Pubitemid 34552489)
46. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK and Christiani DC: The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9: 1037-1042, 2000.
47. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE and Spitz MR: Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16: 2205-2208, 1995.
48. Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC and Tsai CH: Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 112: 116-119, 2002. (Pubitemid 34037747)
49. Shen H, Zheng Y, Sturgis EM, Spitz MR and Wei Q: P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 183: 123-130, 2002. (Pubitemid 34628415)
50. Hsieh YY and Lin CS: P53 codon 11, 72, and 248 gene polymorphisms in endometriosis. Int J Biol Sci 2: 188-193, 2006.
51. Lee HJ, Kim H, Ku SY, Kim SH and Kim JG: Transforming growth factor-beta1 gene polymorphisms in Korean women with endometriosis. Am J Reprod Immunol 66: 428-434, 2011.
52. Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH and Maruo T: Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population. J Soc Gynecol Investig 11: 232-236, 2004. (Pubitemid 38561368)
53. Bianco B, Christofolini DM, Brandes A, Lerner TG, Goncalves-Filho RP, Souza AM and Barbosa CP: Analysis of codon 72 polymorphism of the TP53 gene in infertile women with and without endometriosis. Rev Bras Ginecol Obstet 33: 37-42, 2011 (in Portuguese).
54. Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100, 1999. (Pubitemid 29046852)
55. Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D and Mushinski JF: Molecular cloning, sequencing, chromosomal localization and expression of mouse p21(Waf1). Oncogene 9: 3017-3020, 1994. (Pubitemid 24296779)